Results: 1-25 | 26-50
Results: 1-25/50

Authors: Arase, Y Chayama, K Ikeda, K Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Suzuki, F Akuta, N Someya, T Kobayashi, M Kumada, H
Citation: Y. Arase et al., Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C, HEPATOL RES, 21(1), 2001, pp. 55-66

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration, HEPATOL RES, 19(1), 2001, pp. 22-30

Authors: Iino, S Tango, T Matsushima, T Toda, G Miyake, K Hino, K Kumada, H Yasuda, K Kuroki, T Hirayama, C Suzuki, H
Citation: S. Iino et al., Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis, HEPATOL RES, 19(1), 2001, pp. 31-40

Authors: Morikawa, H Imamura, F Tsurukami, Y Itoh, T Kumada, H Karasawa, S Koga, N Iwamura, H
Citation: H. Morikawa et al., 2,2 '-Bipyridines carrying a diazo moiety and their complexes with bis(hexafluoroacetylacetonato)copper: synthesis, structures, electronic and magnetic properties of their photoproducts in frozen solutions, J MAT CHEM, 11(2), 2001, pp. 493-502

Authors: Murashima, N Ikeda, K Kobayashi, M Saitoh, S Chayama, K Tsubota, A Suzuki, Y Suzuki, F Arase, Y Kumada, H
Citation: N. Murashima et al., Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis, J GASTRO, 36(6), 2001, pp. 368-374

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen, J GASTRO, 36(4), 2001, pp. 242-247

Authors: Someya, T Suzuki, Y Arase, Y Kobayashi, M Suzuki, F Tsubota, A Saitoh, S Chayama, K Murashima, N Ikeda, K Kumada, H
Citation: T. Someya et al., Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant, J GASTRO, 36(2), 2001, pp. 133-136

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Pathogenic significance and organic virus levels in patients infected withTT virus, INTERVIROLO, 44(5), 2001, pp. 291-297

Authors: Ikeda, K Kumada, H
Citation: K. Ikeda et H. Kumada, Adjuvant interferon for hepatocellular carcinoma - Reply, HEPATOLOGY, 33(2), 2001, pp. 482-482

Authors: Chayama, K Suzuki, F Tsubota, A Akuta, N Someya, T Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Ikeda, K Kumada, H
Citation: K. Chayama et al., Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, J VIROL MET, 95(1-2), 2001, pp. 33-45

Authors: Izumi, N Kumada, H Hashimoto, N Harada, H Imawari, M Zeniya, M Toda, G
Citation: N. Izumi et al., Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection - A multicenter randomized study, DIG DIS SCI, 46(3), 2001, pp. 516-523

Authors: Tsubota, AK Arase, Y Ren, FR Tanaka, H Ikeda, K Kumada, H
Citation: Ak. Tsubota et al., Genotype may correlate with liver carcinogenesis and tumor characteristicsin cirrhotic patients infected with hepatitis B virus subtype adw, J MED VIROL, 65(2), 2001, pp. 257-265

Authors: Akuta, N Chayama, K Suzuki, F Someya, T Kobayashi, M Tsubota, A Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: N. Akuta et al., Risk factors of hepatitis C virus-related liver cirrhosis in young adults:Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)0201 allele, J MED VIROL, 64(2), 2001, pp. 109-116

Authors: Arai, M Minatoguchi, S Kumada, H Uno, Y Nishida, Y Hashimoto, K Wang, NY Takemura, G Fujiwara, T Higashioka, M Kuwano, K Fujiwara, H
Citation: M. Arai et al., Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor, BR J PHARM, 133(5), 2001, pp. 635-642

Authors: Matsumura, A Yamamoto, T Shibata, Y Nose, T Yamamoto, K Kumada, H Torii, Y
Citation: A. Matsumura et al., Treatment of malignant brain tumors using nuclear reactor; Neutron capturetherapy, J ATOM E S, 43(10), 2001, pp. 957-963

Authors: Tsubota, A Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Chayama, K Murashima, N Ikeda, K Kobayashi, M Kumada, H
Citation: A. Tsubota et al., Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study, AM J GASTRO, 96(2), 2001, pp. 557-562

Authors: Karasawa, S Kumada, H Koga, N Iwamura, H
Citation: S. Karasawa et al., Magnetic behavior of a 3 : 2 mixture of bis(hexafluoroacetylacetonato)copper(II) and 1,3,5-benzenetriyltris(4-pyridyldiazomethane) in a frozen solution after irradiation: Photochemical formation of a solid solution magnet, J AM CHEM S, 123(39), 2001, pp. 9685-9686

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Tsubota, A Suzuki, F Arase, Y Murashima, N Chayama, K Kumada, H
Citation: K. Ikeda et al., Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data, HEPATOL RES, 18(3), 2000, pp. 252-266

Authors: Hosoda, S Takimura, H Shibayama, M Kanamura, H Ikeda, K Kumada, H
Citation: S. Hosoda et al., Psychiatric symptoms related to interferon therapy for chronic hepatitis C: Clinical features and prognosis, PSY CLIN N, 54(5), 2000, pp. 565-572

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course, J GASTRO, 35(8), 2000, pp. 607-612

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Arase, Y Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, J GASTRO, 35(5), 2000, pp. 353-360

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C, J GASTRO, 35(3), 2000, pp. 221-225

Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Murashima, N Ikeda, K Hagiwara, M Hashimoto, R Nakagawa, M Matsuda, M Kumada, H
Citation: M. Kobayashi et al., Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance, J GASTRO, 35(10), 2000, pp. 753-757

Authors: Kariwa, H Yoshimatsu, K Araki, K Chayama, K Kumada, H Ogino, M Ebihara, H Murphy, ME Mizutani, T Takashima, I Arikawa, J
Citation: H. Kariwa et al., Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in Japan, MICROB IMMU, 44(5), 2000, pp. 357-362

Authors: Kumada, H Sakane, A Koga, N Iwamura, H
Citation: H. Kumada et al., Through-bond magnetic interaction between the 2p spin of the aminoxyl radical and the 3d spin of the metal ions in the complexes of bis(hexafluoroacetylacetonato)-manganese(II) and -copper(II) with 4-(N-tert-butyl-N-oxylamino)-2,2 '-bipyridine, J CHEM S DA, (6), 2000, pp. 911-914
Risultati: 1-25 | 26-50